BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Policy

  The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva Parenteral Medicines, Inc.

  October 3, 2011

   · 

  4 min read
• Genetown

  Cellceutix’s Drug Discovery is a Major Leap Forward in the Fight Against Cancer

  October 3, 2011

   · 

  3 min read
• Biotech Bay

  Burrill & Company Release: Debt Worries, Political Dysfunction Take a Toll on Biotech in Third Quarter

  October 3, 2011

   · 

  8 min read
• Drug Development

  Journal of Immunology Publishes Study of Cleveland Biolabs Inc.’ Drug CBLB502 in Acute Renal Ischemic Failure

  October 3, 2011

   · 

  4 min read
• Pharm Country

  The Medicines Company Launches New Formulation of Cleviprex(R) (Clevidipine) Injectable Emulsion

  October 3, 2011

   · 

  5 min read
• BioMidwest

  CDEX Inc. Ships ValiMed G4 Medication Validation System

  October 3, 2011

   · 

  2 min read
• IBA’s Family of Proton Beam Solutions Suits Diverse Budgets, Sites and Clinical Needs

  October 3, 2011

   · 

  1 min read
• Genetown

  Decision Resources Group Release: Biosimilar Versions of TNF-alpha Inhibitors and Pegylated IFN-alpha Agents Will Save Healthcare Systems $5.3 Billion in 2020

  October 3, 2011

   · 

  1 min read
• Genetown

  Idera Pharmaceuticals, Inc. Announces Presentation at 2nd Annual Cancer Immunotherapy Conference

  October 3, 2011

   · 

  1 min read
• GE Healthcare Announces 25 ‘GE Global Pink Ribbons’ to Mark Breast Cancer Awareness Month

  October 3, 2011

   · 

  1 min read